Skip to main navigation

Skip links

  • Skip to content
  • Skip to footer

Akari TX

Main navigation

Menu
  • Home
  • About
    • Company Overview
    • Management
    • Board of Directors
    • CEO CORNER
    • Scientific Advisory Board
  • Areas of Focus
    • Pipeline
    • Posters & Publications
    • Legacy Pipeline Assets
  • Investor Relations
    • Overview
    • Corporate Governance
      • Governance Overview
      • Board of Directors
      • Management
      • Committee Composition
    • Financial Information
      • SEC Filings
      • Annual Reports
    • News & Presentations
      • Press Releases
      • Presentations
    • Analyst Coverage
    • Stock Information
      • Stock Quote & Chart
      • Historic Price Lookup
    • Email Alerts
  • Press
    • Press Releases
    • Stories
  • Contact Us

8-K

SEC Filing Details

Document Details

Form
8-K
Filing Date
Mar 17, 2026
Document Date
Mar 17, 2026
Form Description
Report of unscheduled material events or corporate event
Filing Group
Current Reports
Company
Akari Therapeutics
Issuer
AKARI THERAPEUTICS PLC

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
EX-101.DEF - XBRL DEFINITION FILE
EX-101.LAB - XBRL LABEL FILE
EX-101.PRE - XBRL PRESENTATION FILE
XML - XBRL INSTANCE DOCUMENT
Tools
  • Print Page
  • Email Alerts
  • RSS Feeds
  • Contact Us

Footer

Follow Us

Terms of Use
Privacy Statement
Contact Us

Akari TX

Copyright © 2026 Akari Therapeutics Plc. All rights reserved.